IL144842A0 - Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant - Google Patents

Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant

Info

Publication number
IL144842A0
IL144842A0 IL14484200A IL14484200A IL144842A0 IL 144842 A0 IL144842 A0 IL 144842A0 IL 14484200 A IL14484200 A IL 14484200A IL 14484200 A IL14484200 A IL 14484200A IL 144842 A0 IL144842 A0 IL 144842A0
Authority
IL
Israel
Prior art keywords
artificial
preparation
surface activity
surfactant
peptides
Prior art date
Application number
IL14484200A
Other languages
English (en)
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of IL144842A0 publication Critical patent/IL144842A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785Alveolar surfactant peptides; Pulmonary surfactant peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14484200A 1999-02-12 2000-02-09 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant IL144842A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000275A IT1308180B1 (it) 1999-02-12 1999-02-12 Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
PCT/EP2000/001044 WO2000047623A1 (en) 1999-02-12 2000-02-09 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant

Publications (1)

Publication Number Publication Date
IL144842A0 true IL144842A0 (en) 2002-06-30

Family

ID=11381859

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14484200A IL144842A0 (en) 1999-02-12 2000-02-09 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant

Country Status (33)

Country Link
US (1) US7053044B1 (hu)
EP (1) EP1151008B1 (hu)
JP (1) JP4754073B2 (hu)
KR (1) KR100645145B1 (hu)
CN (1) CN1221570C (hu)
AR (1) AR022578A1 (hu)
AT (1) ATE280181T1 (hu)
AU (1) AU758735B2 (hu)
BG (1) BG65196B1 (hu)
BR (1) BR0009964A (hu)
CA (1) CA2362507C (hu)
CO (1) CO5241361A1 (hu)
CZ (1) CZ301108B6 (hu)
DE (1) DE60015082T2 (hu)
EA (1) EA004058B1 (hu)
EE (1) EE04879B1 (hu)
ES (1) ES2228473T3 (hu)
GE (1) GEP20032976B (hu)
HK (1) HK1042500A1 (hu)
HU (1) HU228997B1 (hu)
IL (1) IL144842A0 (hu)
IT (1) IT1308180B1 (hu)
MA (1) MA25381A1 (hu)
NO (1) NO20013888D0 (hu)
NZ (1) NZ513451A (hu)
PL (1) PL201084B1 (hu)
PT (1) PT1151008E (hu)
SK (1) SK286428B6 (hu)
TR (1) TR200102308T2 (hu)
UA (1) UA72751C2 (hu)
WO (1) WO2000047623A1 (hu)
YU (1) YU57701A (hu)
ZA (1) ZA200106530B (hu)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
CA2399944A1 (en) * 2000-02-11 2001-08-16 Altana Pharma Ag Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
SI1340506T1 (sl) * 2002-03-01 2007-04-30 Chiesi Farma Spa Sestavki, ki vsebujejo pljucne surfaktante in polimiksin z izboljsanimi povrsinskimi lastnostmi
ITMI20021058A1 (it) 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
CN100401896C (zh) * 2002-12-09 2008-07-16 儿童医院医疗中心 诊断和治疗间质性肺病的方法
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
CA2536453A1 (en) * 2003-08-28 2005-03-10 Altana Pharma Ag Use of surfactant preparations for the treatment of surgical adhesions
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
CA2658478C (en) 2006-07-20 2018-02-13 University Of Rochester Synthetic lung surfactant and use thereof
DK2078038T3 (da) * 2006-10-13 2013-12-02 Chiesi Farma Spa Rekonstituerede surfaktanter med forbedrede egenskaber
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8048043B2 (en) 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
AR074874A1 (es) 2008-12-23 2011-02-16 Biosource Pharm Inc Composiciones antibioticas para el tratamiento de infecciones gram negativas. metodo. uso. compuesto.
CN102470150B (zh) 2009-09-08 2013-12-11 奇斯药制品公司 包含肺表面活性物质和抗氧化酶的治疗组合物
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
MA37431B1 (fr) * 2012-04-23 2016-06-30 Chiesi Farma Spa Procédé et système pour l'administration d'un surfactant pulmonaire par atomisation
AR093569A1 (es) 2012-11-21 2015-06-10 Chiesi Farm Spa Tensioactivos pulmonares reconstituidos
CN107666933A (zh) 2015-04-22 2018-02-06 奇斯药制品公司 用于药物有效地呼吸同步递送到肺部的方法和系统
EP3106090A1 (en) 2015-06-15 2016-12-21 CHIESI FARMACEUTICI S.p.A. System for effective breath-synchronized delivery of medicament to the lungs
US11311691B2 (en) 2015-04-28 2022-04-26 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
EP3288579A1 (en) 2015-04-30 2018-03-07 University of Bremen A novel skin medical and cosmetic care product
EP3490649A1 (en) 2016-07-28 2019-06-05 Chiesi Farmaceutici S.p.A. Method and system for delivery of an aerosolized medicament
CN109890446B (zh) 2016-10-26 2022-03-22 奇斯药制品公司 用于帮助通过导管向肺给送药剂的装置
RU2757902C2 (ru) 2016-12-22 2021-10-22 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Терапевтическая комбинация для лечения развивающейся bpd, содержащая легочный сурфактант и стероид
WO2019115771A1 (en) 2017-12-15 2019-06-20 Pari Pharma Gmbh Nebuliser system, holding system, combination comprising nebuliser system and holding system, and aerosol administration method
TW201927286A (zh) 2017-12-15 2019-07-16 義大利商凱西製藥公司 用於噴霧投藥之包含肺表面張力素的藥學調配物
WO2019206731A1 (en) 2018-04-23 2019-10-31 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of bpd
EP3666315A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3666316A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3843105A1 (en) 2019-12-23 2021-06-30 PARI Pharma GmbH Control device for aerosol nebulizer system
WO2021151853A1 (en) 2020-01-28 2021-08-05 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
CN114159546B (zh) * 2021-12-20 2024-06-04 北京双鹤润创科技有限公司 新一代合成肺表面活性物质制剂及其临床应用
EP4411745A1 (en) 2023-02-01 2024-08-07 Pari Medical Holding GmbH Medical evaluation method, aerosol nebulizer and medical evaluation system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104853A (en) 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
ES2189825T3 (es) * 1993-12-08 2003-07-16 Mitsubishi Pharma Corp Nuevo peptido sintetico, tensioactivo pulmonar que lo contiene y remedio para el sindrome de malestar respiratorio.
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante

Also Published As

Publication number Publication date
EA200100749A1 (ru) 2002-02-28
KR20010101904A (ko) 2001-11-15
MA25381A1 (fr) 2002-04-01
HK1042500A1 (en) 2002-08-16
EE04879B1 (et) 2007-08-15
SK11442001A3 (sk) 2001-12-03
HUP0200141A3 (en) 2002-09-30
CA2362507A1 (en) 2000-08-17
ZA200106530B (en) 2002-10-14
HU228997B1 (en) 2013-07-29
PL201084B1 (pl) 2009-03-31
CZ301108B6 (cs) 2009-11-11
BG65196B1 (bg) 2007-06-29
ES2228473T3 (es) 2005-04-16
BG105764A (en) 2002-03-29
CN1340060A (zh) 2002-03-13
DE60015082T2 (de) 2006-02-09
YU57701A (sh) 2003-07-07
NO20013888L (no) 2001-08-09
CN1221570C (zh) 2005-10-05
BR0009964A (pt) 2002-04-09
CZ20012876A3 (cs) 2002-06-12
ITMI990275A1 (it) 2000-08-12
NO20013888D0 (no) 2001-08-09
PL349785A1 (en) 2002-09-09
US7053044B1 (en) 2006-05-30
IT1308180B1 (it) 2001-12-07
CA2362507C (en) 2012-01-03
HUP0200141A2 (en) 2002-06-29
GEP20032976B (en) 2003-05-27
EA004058B1 (ru) 2003-12-25
KR100645145B1 (ko) 2006-11-10
SK286428B6 (sk) 2008-09-05
EP1151008B1 (en) 2004-10-20
NZ513451A (en) 2003-05-30
TR200102308T2 (tr) 2002-04-22
JP4754073B2 (ja) 2011-08-24
WO2000047623A1 (en) 2000-08-17
PT1151008E (pt) 2005-01-31
JP2002541062A (ja) 2002-12-03
EE200100413A (et) 2002-12-16
DE60015082D1 (de) 2004-11-25
AU758735B2 (en) 2003-03-27
CO5241361A1 (es) 2003-01-31
AU3279300A (en) 2000-08-29
AR022578A1 (es) 2002-09-04
ATE280181T1 (de) 2004-11-15
EP1151008A1 (en) 2001-11-07
UA72751C2 (en) 2005-04-15

Similar Documents

Publication Publication Date Title
IL144842A0 (en) Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
HUP0203367A3 (en) Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
HK1047250A1 (zh) 組織填補物料和方法
IL145715A0 (en) Formulation arrays and use thereof
HUP0203811A3 (en) Use of polymeric material in the treatment of hard surfaces
HUP0000963A3 (en) The use of levobupivacaine in paediatric surgery
HUP0000873A3 (en) The use of levobupivacaine in facial surgery
IL152202A0 (en) Human kcnq5 polypeptide and pharmaceutical compositions containing the same
ZA983239B (en) Stable active human ob protein compositions and methods
EP1086215A4 (en) PREPARATION AND USE OF HIGHER VACCINES
EP1308509A4 (en) NEW, PHYSIOLOGICALLY ACTIVE PEPTIDE AND ITS APPLICATIONS
IL131719A0 (en) Iren protein its preparation and use
SI1151008T1 (en) Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
GB2351459B (en) Improvements in and relating to the application of materials
GB9912085D0 (en) Use of amino acids in hair treatment
EP1275659A4 (en) PHYSIOLOGICALLY ACTIVE PEPTIDES AND THEIR USE
NZ329917A (en) Peptides having somatostatin antagonistic activity and their use in the enhancement of meat production
IL156077A0 (en) Analogues of thiocoraline and be-22179
IL145527A0 (en) Retro-inverso prosaposin-derived peptides and use thereof
GB9929581D0 (en) Comjpositions and their use
EP1150685A4 (en) SURFACTANTS BASED ON PHOSPHOCHOLINE AND USES THEREOF
HK1047116A1 (zh) 來自mage的免疫原性肽及其應用
HUP0200775A3 (en) Use of pegylated interferon-alpha in melanoma therapy
GB9905300D0 (en) Therapy and use of agents in therapy